Kronos Bio LLC

Kronos Bio LLC EBIT

Delisted

The EBIT of Kronos Bio LLC (KRON) as of Nov 2, 2026 is -92.89 M USD. In the previous year, EBIT was -121.83 M USD — a change of -23.76% (higher).

EBIT

-92.89 MUSD

YoY

-23.76%

Last updated:

In 2024, Kronos Bio LLC's EBIT was -92.89 M USD, a -23.76% increase from the -121.83 M USD EBIT recorded in the previous year.

The Kronos Bio LLC EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2024
-92.89 M USD
Jan 1, 2025 (e)
433,333.00 USD
Jan 1, 2026 (e)
2.57 M USD
Jan 1, 2027 (e)
3.00 M USD
Jan 1, 2028 (e)
9.00 M USD
Jan 1, 2029 (e)
-60.18 M USD
Jan 1, 2030 (e)
-57.12 M USD
Jan 1, 2031 (e)
0.00 USD
The Kronos Bio LLC EBIT history
YEAREBITYoY
est0.00USD-100.00%
est-57.12 MUSD-5.08%
est-60.18 MUSD-768.67%
est9.00 MUSD+200.00%
est3.00 MUSD+16.89%
est2.57 MUSD+492.29%
est433,333.00USD-100.47%
-92.89 MUSD-23.76%
-121.83 MUSD-11.15%
-137.12 MUSD-9.43%
-151.40 MUSD+79.05%
-84.55 MUSD+402.82%
-16.82 MUSD+153.06%
-6.65 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Kronos Bio LLC Revenue

Kronos Bio LLC Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2024
9.85 M USD
-92.89 M USD
-86.08 M USD
Jan 1, 2025 (e)
2.17 M USD
433,333.00 USD
-79.26 M USD
Jan 1, 2026 (e)
12.83 M USD
2.57 M USD
-82.31 M USD
Jan 1, 2027 (e)
15.00 M USD
3.00 M USD
-60.97 M USD
Jan 1, 2028 (e)
45.00 M USD
9.00 M USD
-54.87 M USD
Jan 1, 2029 (e)
71.40 M USD
-60.18 M USD
0.00 USD
Jan 1, 2030 (e)
96.90 M USD
-57.12 M USD
0.00 USD
Jan 1, 2031 (e)
122.40 M USD
0.00 USD
0.00 USD

Kronos Bio LLC Margins

Kronos Bio LLC stock margins

The Kronos Bio LLC margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Kronos Bio LLC. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Kronos Bio LLC.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2024
100.00 %
-943.21 %
-874.08 %
Jan 1, 2025 (e)
100.00 %
20.00 %
-3,658.20 %
Jan 1, 2026 (e)
100.00 %
20.00 %
-641.39 %
Jan 1, 2027 (e)
100.00 %
20.00 %
-406.47 %
Jan 1, 2028 (e)
100.00 %
20.00 %
-121.94 %
Jan 1, 2029 (e)
100.00 %
-84.29 %
0.00 %
Jan 1, 2030 (e)
100.00 %
-58.95 %
0.00 %
Jan 1, 2031 (e)
100.00 %
0.00 %
0.00 %

Kronos Bio LLC Stock analysis

What does Kronos Bio LLC do? Kronos Bio Inc is a biotech company founded in 2017 by an experienced team, specialized in developing new therapeutics for cancer treatment. The company is based in Cambridge, Massachusetts and collaborates closely with leading scientific institutions. Kronos Bio Inc's business model focuses on identifying and researching new targets to develop drugs for the treatment of cancer and other diseases. The company utilizes artificial intelligence and machine learning to identify molecular mechanisms, enabling better prediction of the effectiveness of new drugs. Kronos Bio Inc is divided into different divisions, each focusing on specific therapeutic approaches. The "Transcription Regulation" division explores the control of gene expression in tumor cells and seeks potential points of intervention. The "Epigenetics" division, on the other hand, investigates how cells modify their DNA and the role this plays in the development of cancer. Another division focuses on blocking specific enzyme activities that are considered essential factors for the growth of tumor cells. Currently, Kronos Bio Inc does not offer concrete products as it is still in the development phase. However, the company has already established a number of collaborations with other companies and scientific institutions to research and further develop new drug candidates. One of the most significant partnerships is with the pharmaceutical company Gilead Sciences, which has the option to license selected drug candidates from Kronos Bio Inc as part of the collaboration. Overall, Kronos Bio has quickly made a name for itself in the biotech industry with its innovative approach and ambitious plans to develop new drugs against cancer. The company has raised several million dollars in capital and has prominent investors such as Omega Funds and Vida Ventures on board. The goal of Kronos Bio is to develop new therapies that allow for improved survival rates and a higher quality of life for cancer patients. Kronos Bio LLC is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Kronos Bio LLC's EBIT

Kronos Bio LLC's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Kronos Bio LLC's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Kronos Bio LLC's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Kronos Bio LLC’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Kronos Bio LLC stock

EBIT of Kronos Bio LLC is -92.89 M USD in 2024.

EBIT of Kronos Bio LLC changed from -121.83 M USD to -92.89 M USD, representing a -23.76% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Kronos Bio LLC since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Kronos Bio LLC historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Kronos Bio LLC

All Key Metrics — Kronos Bio LLC